These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3180147)

  • 1. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
    Stone MJ; Tong AW; Fay JW; Lee JC
    Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
    Tong AW; Dalton WS; Tsuruo T; Fay JW; Stone MJ
    Prog Clin Biol Res; 1990; 333():155-64. PubMed ID: 2308979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody.
    Tong AW; Lee J; Wang RM; Dalton WS; Tsuruo T; Fay JW; Stone MJ
    Cancer Res; 1989 Sep; 49(17):4829-34. PubMed ID: 2569359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell-reactive monoclonal antibody and complement.
    Tong AW; Lee JC; Fay JW; Stone MJ
    Blood; 1987 Nov; 70(5):1482-9. PubMed ID: 3663943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
    Bast RC; De Fabritiis P; Lipton J; Gelber R; Maver C; Nadler L; Sallan S; Ritz J
    Cancer Res; 1985 Feb; 45(2):499-503. PubMed ID: 3967224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement depletion in vitro limits monoclonal antibody 6-19-dependent complement-mediated killing of tumor cells in bone marrow.
    Duerst RE; Rose D; Frantz CN
    Exp Hematol; 1991 Oct; 19(9):863-7. PubMed ID: 1893961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis.
    Frame JN; Sheehy D; Cartagena T; Cirrincione C; O'Reilly RJ; Dupont B; Kernan NA
    Bone Marrow Transplant; 1989 Jan; 4(1):55-61. PubMed ID: 2784335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.
    Tong AW; Huang YW; Zhang BQ; Netto G; Vitetta ES; Stone MJ
    Anticancer Res; 1993; 13(3):593-7. PubMed ID: 8391243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Uckun FM; Ramakrishnan S; Houston LL
    J Immunol; 1985 Mar; 134(3):2010-6. PubMed ID: 3855433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
    Haleem A; Kurtzberg J; Olsen GA; Rhinehardt-Clark A; Leslie DS; Ray L; Smith CA; Peters WP; Haynes BF; Bast RC
    Cancer Res; 1987 Sep; 47(17):4608-12. PubMed ID: 3113721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
    Montgomery RB; Kurtzberg J; Rhinehardt-Clark A; Haleen A; Ramakrishnan S; Olsen GA; Peters WP; Smith CA; Haynes BF; Houston LL
    Bone Marrow Transplant; 1990 Jun; 5(6):395-402. PubMed ID: 2369680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
    Hu ZB; Yu ZF; Qiao CN; Ma WL
    Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
    Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
    Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeads.
    Shimazaki C; Wisniewski D; Scheinberg DA; Atzpodien J; Strife A; Gulati S; Fried J; Wisniewolski R; Wang CY; Clarkson BD
    Blood; 1988 Oct; 72(4):1248-54. PubMed ID: 3167207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
    Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
    Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.